Navigation Links
Will MHLW Changes in Reimbursement Drive Japanese Physicians to Increase Usage of Chronic Dialysis Catheters?
Date:9/7/2010

TORONTO, Sept. 7 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, changes in Japan's Ministry of Health Labour and Welfare (MHLW) reimbursement, which encourage facilities to use higher-priced chronic dialysis catheters, will lead to double-digit growth in this segment over the next five years, and will support overall market revenues.

Unlike in the US and Europe, where chronic dialysis catheters have seen strong adoption, Japanese physicians have long preferred acute catheters, which accounted for nearly 98% of unit sales in 2009. Physicians in Japan prefer the less invasive procedure involved with inserting an acute catheter, due in part to a strong cultural aversion to invasive procedures, which would be required by a chronic catheter placement. Because acute dialysis catheters are less expensive than chronic dialysis catheters, their historical popularity has limited potential dialysis catheter revenues in Japan.

"As a result of the strong physician preference for acute dialysis catheters, compounded with pricing declines in this segment, the Japanese dialysis catheter market shrank in 2009," says April Lee, Analyst at MRG.  "This market will, however, grow through 2014, partly due to the MHLW's implementation of a new procedural reimbursement that provides hospitals with an incentive to perform the chronic dialysis catheter insertions."

In addition to favorable changes in reimbursement, chronic dialysis catheters offer several benefits, including increased longevity, compared to acute catheters.  They allow physicians to access the super vena cava directly rather than through the peripheral veins, which is advantageous for elderly patients who tend to have weaker peripheral vasculature. Consequently, chronic dialysis catheters will be increasingly adopted as a temporary form of vascular access. Because these devices are expensive compared to acute dialysis catheters, their increasing adoption will support prices and revenues through 2014. Although chronic catheter adoption is awakening in Japan, the country shows no signs of adopting antimicrobial-coated devices, which are gaining popularity in other regions due to their ability to reduce infection rates. Antimicrobial devices were released in Japan in 2000, but several patients died as a result of severe adverse reactions to the coatings.  As a result, the MHLW removed the devices from the market and they have not been reintroduced.

MRG's Japanese Markets for Vascular Access Devices 2010 report provides critical insight into trends that will fuel market growth for short peripheral intravenous catheters, central venous catheters, implantable ports, dialysis catheters, and peripherally inserted central catheters through 2014.  

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101akrohn@mrg.netChris ComfortDecision Resources, Inc. 781-993-2597ccomfort@dresources.com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Micromet Announces Changes in Management Team
3. Cancer Cure Coalition Proposes Major Changes at the FDA
4. Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
5. Silence Therapeutics Announces Board Changes
6. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
7. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
8. Exercise Helps Prevent Age-Related Brain Changes in Older Adults
9. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
10. Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion
11. Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , Israel and TAMPA, Fla. , ... an emerging medical device company focused on developing ... procedures, applauds the members of the FDA,s Circulatory ... for their acknowledgement of the need for cerebral ... "The statements shared by this FDA ...
(Date:2/27/2017)... 2017 Now in its seventh year, ... are most successful at developing and commercialising innovation. ... The Index can ... molecule to two different companies in early phase, which would ... objective analysis of each company,s performance between 2011 and 2016, the 2017 ...
(Date:2/27/2017)... Period October – December 2016 ... to SEK -16.4 (-6.4) million Result after tax amounted to ... after dilution Cash flow from operating activities amounted to SEK ... Period full ... Operating result amounted to SEK -39.5 (-29.5) million ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... wholesale distribution in North America, today announced it would be offering some it’s ... which prides itself on crafting quality and unique baby clothing/feeding products, will team ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive and ... the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, ...
(Date:2/26/2017)... Florida (PRWEB) , ... February 26, 2017 , ... ... (PD) patients after receiving cognitive rehabilitation, according to a study released today at ... known that cognitive rehabilitation programs are proven to be effective in improving cognitive ...
(Date:2/25/2017)... ... 25, 2017 , ... FCPX users now have the ability to sharpen a ... ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, ... spectrum tools users can visually see the color range effected with ease all within ...
Breaking Medicine News(10 mins):